Overview
Following parenteral administration, dermorphin distributes rapidly to CNS compartments due to its moderate lipophilicity and small molecular size. Receptor occupancy studies in rodents demonstrate saturation of spinal and supraspinal MOR populations at doses of 1–5 mcg/kg subcutaneously. MOR activation in the nucleus accumbens shell additionally engages dopaminergic reward circuitry via disinhibition of GABAergic interneurons projecting to ventral tegmental area (VTA) dopamine neurons, contributing to reinforcing and potentially addictive properties. Respiratory depression results from MOR activation in the pre-Bötzinger complex of the brainstem, a primary center for respiratory rhythm generation.
Proposed mechanism
Dermorphin acts as a highly selective full agonist at mu-opioid receptors (MOR, OPRM1), activating Gi/o protein-coupled signaling cascades that reduce adenylyl cyclase activity, decrease intracellular cAMP, hyperpolarize neurons via GIRK channels, and inhibit voltage-gated calcium channels. This results in profound suppression of pain signal transmission in both the spinal cord and supraspinal regions. Its unusual D-amino acid (D-Ala at position 2) confers exceptional resistance to enzymatic degradation, prolonging its biological activity compared to endogenous opioid peptides.
What the evidence supports
Most data comes from preclinical animal studies. Human clinical trial evidence is limited or absent.
Graded Animal
Evidence drawn from in vivo animal models or in vitro systems. Mechanistically informative; translation to humans is unproven.
Key citations
Representative primary sources, including results that did not favour the compound.
- [1]
Erspamer V, Melchiorri P, Falconieri-Erspamer G et al. — Deltorphins: a family of naturally occurring peptides with high affinity and selectivity for delta opioid binding sites
· Proceedings of the National Academy of Sciences USA 86(13):5188–5192 · 1989
- [2]
Negri L, Melchiorri P, Lattanzi R — Pharmacology of amphibian opiate peptides
· Peptides 21(7):1029–1048 · 2000
- [3]
Broccardo M, Erspamer V, Falconieri-Erspamer G et al. — Pharmacological data on dermorphins, a new class of potent opioid peptides from amphibian skin
· British Journal of Pharmacology 73(3):625–631 · 1981
- [4]
Lazarus LH, Salvadori S — Dermorphin and its analogs
· NIDA Research Monograph 105:138–156 · 1991
Citation records in this build are illustrative placeholders for the design.
Reference information for research purposes. Not medical advice, and not a recommendation to use any compound. Many entries describe substances that are not approved for human use.